Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drugnews2025-05-12T00:08:25+00:00May 12th, 2025|The New York Times|
Sybil Shainwald, Lawyer Who Fought for Women’s Health, Dies at 96news2025-05-04T20:04:26+00:00May 4th, 2025|The New York Times|
What to Know About Eli Lilly’s Daily Pill for Weight Lossnews2025-04-17T21:24:51+00:00April 17th, 2025|The New York Times|
Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycatsnews2025-04-16T14:43:02+00:00April 16th, 2025|The New York Times|
Trump’s Tariff Threat for Drug imports Poses Big Political Risksnews2025-04-15T14:33:12+00:00April 15th, 2025|The New York Times|
Eli Lilly Drug Reduces Mysterious Lp(a) Particle Involved in Heart Attack Risknews2025-03-30T18:30:06+00:00March 30th, 2025|The New York Times|
Experts Say GLP-1 Drugs Have Potential Use Beyond Weight Lossnews2024-12-04T23:10:42+00:00December 4th, 2024|The New York Times|
Eli Lilly Chief Says He Will Fight for the FDA, Challenging RFK Jr.’s Stancenews2024-12-04T21:23:56+00:00December 4th, 2024|The New York Times|
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trialsnews2024-10-23T14:19:56+00:00October 23rd, 2024|The New York Times|
Eli Lilly’s Popular Weight Loss Drug, Zepbound, Is Getting a Price Cutnews2024-08-27T10:45:07+00:00August 27th, 2024|The New York Times|
